SCHEMBL17541791

SCHEMBL17541791

COc1ccc(COc2ccc3c(c2)CN(c2ccc(=O)n(C)n2)C3)nc1

nearest known ligand 0.40

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ GRM5 P41594 1/20 0.40
▸ TIPARP Q7Z3E1 4/20 0.39
▸ MCHR1 Q99705 11/20 0.38
▸ PDE10A Q9Y233 1/20 0.37
▸ SLC6A3 Q01959 1/20 0.36
▸ CYP3A4 P08684 1/20 0.35
▸ KCNH2 Q12809 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23562064 0.92 GRM5 (0.42) GRM5TIPARPMCHR1PDE10A
SCHEMBL24667446 0.85 MCHR1 (0.33) TIPARPMCHR1PDE10A
SCHEMBL17541808 0.84 TIPARP (0.48) TIPARP
SCHEMBL29987375 0.83 GRM5 (0.42) GRM5MCHR1PDE10ASLC6A3
SCHEMBL24667346 0.83 GRM5 (0.42) GRM5MCHR1PDE10ASLC6A3
SCHEMBL29987068 0.83 GRM5 (0.42) GRM5MCHR1PDE10ASLC6A3
SCHEMBL24667632 0.83 GRM5 (0.42) GRM5MCHR1PDE10ASLC6A3
SCHEMBL24667400 0.81 GRM5 (0.42) GRM5MCHR1PDE10ASLC6A3CYP3A4
SCHEMBL29986550 0.81 GRM5 (0.42) GRM5MCHR1PDE10ASLC6A3CYP3A4
SCHEMBL24667378 0.78 GRM5 (0.40) GRM5MCHR1PDE10ASLC6A3CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12036291-B2 Probes for imaging huntingtin protein CHDI FOUNDATION, INC. (US) 2024-07-16 — — US claimed
CN-107074817-B Probes for imaging huntingtin CHDI基金会股份有限公司 2023-12-15 — — CN claimed
US-20210379211-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN CHDI FOUNDATION, INC. 2021-12-09 — — US claimed
US-11071793-B2 Probes for imaging huntingtin protein CHDI FOUNDATION, INC. (US) 2021-07-27 — — US claimed
EP-3186241-B1 PROBES FOR IMAGING HUNTINGTON PROTEIN CHDI FOUNDATION INC (US) 2020-10-07 — — EP claimed
US-20170281804-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN EVOTEC (UK) LTD. (GB) 2017-10-05 — — US claimed
EP-3186241-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN CHDI Foundation, Inc. (US) 2017-07-05 — — EP claimed
WO-2016033436-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN CHDI FOUNDATION, INC. (US) 2016-03-03 — — WO claimed
US-12083108-B2 Compounds for targeting mutant huntingtin protein and uses thereof CHDI FOUNDATION, INC. (US) 2024-09-10 — — US disclosed
US-12036291-B2 Probes for imaging huntingtin protein CHDI FOUNDATION, INC. (US) 2024-07-16 — — US disclosed
US-12036291-B2 Probes for imaging huntingtin protein CHDI FOUNDATION, INC. (US) 2024-07-16 — — US disclosed
US-12036291-B2 Probes for imaging huntingtin protein CHDI FOUNDATION, INC. (US) 2024-07-16 — — US disclosed
CN-118005611-A Probes for imaging huntingtin CHDI基金会股份有限公司 2024-05-10 — — CN disclosed
CN-107074817-B Probes for imaging huntingtin CHDI基金会股份有限公司 2023-12-15 — — CN disclosed
US-20170281804-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN EVOTEC (UK) LTD. (GB) 2017-10-05 — — US disclosed
US-20170281804-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN EVOTEC (UK) LTD. (GB) 2017-10-05 — — US disclosed
US-20170281804-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN EVOTEC (UK) LTD. (GB) 2017-10-05 — — US disclosed
EP-3186241-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN CHDI Foundation, Inc. (US) 2017-07-05 — — EP disclosed
WO-2016033436-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN CHDI FOUNDATION, INC. (US) 2016-03-03 — — WO disclosed
WO-2016033436-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN CHDI FOUNDATION, INC. (US) 2016-03-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210379211-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN HTT, HYPK, HSPBP1 GRM5 1486/4885TIPARP 2113/4885MCHR1 541/4885
US-11071793-B2 Probes for imaging huntingtin protein HTT, HYPK, HSPBP1 GRM5 1486/4885TIPARP 2113/4885MCHR1 541/4885
US-12083108-B2 Compounds for targeting mutant huntingtin protein and uses thereof HTT, HYPK, UBQLN2 GRM5 1231/4885TIPARP 128/4885MCHR1 2842/4885
US-20170281804-A1 PROBES FOR IMAGING HUNTINGTIN PROTEIN HTT, HYPK, HSPBP1 GRM5 1486/4885TIPARP 2113/4885MCHR1 541/4885
US-12036291-B2 Probes for imaging huntingtin protein HTT, HYPK, HSPBP1 GRM5 1486/4885TIPARP 2113/4885MCHR1 541/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback